EQS-News: Aclarion, Inc. / Key word (s): Financial Aclarion Announces Closing of $14.4 Million Public Offering of Common Stock and Warrants 17.01.2025 / 22:50 CET/CEST The issuer is solely ...

Aclarion, Inc. ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help ...

(Nasdaq: ACON), a company specializing in cutting-edge healthcare technology, saw its stock price surge by +6.44%, reaching $0.0479 during Friday’s premarket trading session. The jump follows the ...

In recent trading, Aclarion Inc (ACON) stock price has shown some volatility, fluctuating -67.49% over the last five trades and -57.14% over the past 30 trades. This represents a notable shift from ...

BROOMFIELD, CO - January 15, 2025 (NEWMEDIAWIRE) - Aclarion, Inc. ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary ...

BROOMFIELD, CO - January 15, 2025 (NEWMEDIAWIRE) - Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that ...

Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to ...

Aclarion disclosed its plans to utilize the net proceeds from the transaction to support market development and clinical evidence, product development and quality, general and administration ...

Aclarion, Inc. (NASDAQ: ACON) recently disclosed the outcomes of its 2024 Annual Meeting of Stockholders in a Form 8-K filing with the Securities and Exchange Commission. The meeting, which took place ...